Blue Sail Medical Co.,Ltd. (002382.SZ)
CNY 5.24
(-1.69%)
CNY 5.24
(-1.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -72.88 Million | 494.46 Million | 2.24 Billion | 3.67 Billion | 782.78 Million | 649.36 Million |
| Net Income | -568.36 Million | -372.31 Million | 1.15 Billion | 1.76 Billion | 519.45 Million | 355.33 Million |
| Depreciation & Amortization | 524.51 Million | 489 Million | 332.16 Million | 213.7 Million | 185.75 Million | 135.04 Million |
| Deferred income taxes | -98.15 Million | -59.22 Million | 10.82 Million | -28.98 Million | -24.5 Million | -26.24 Million |
| Stock-based compensation | 20.45 Million | - | -19.62 Million | - | - | 1.86 Million |
| Change in working capital | -292.35 Million | 364.76 Million | -453.63 Million | -302.6 Million | -39.07 Million | 75.48 Million |
| Other non-cash items | 210.78 Million | 115.47 Million | 1.22 Billion | 1.99 Billion | 116.64 Million | 83.49 Million |
| Investing Cash Flow | -870.74 Million | 114.81 Million | -2.49 Billion | -3.64 Billion | -388.31 Million | -1.87 Billion |
| Investments in PPE | -774.14 Million | -896.86 Million | -2.58 Billion | -1.2 Billion | -356.68 Million | -441.09 Million |
| Acquisitions | 2.56 Million | -53.25 Million | 6.36 Million | -708.8 Million | 1.99 Million | -1.36 Billion |
| Investment purchases | -398 Million | -609 Million | -2.37 Billion | -2.44 Billion | -100.56 Million | -136.5 Million |
| Sales/Maturities of investments | 298.83 Million | 1.66 Billion | 2.46 Billion | 704.06 Million | 63.63 Million | 67.75 Million |
| Other Investing Activities | -96.6 Million | 10.98 Million | 1.09 | 7.43 Million | 3.3 Million | 2.82 Million |
| Financing Cash Flow | 133.3 Million | -711.69 Million | -977.01 Million | 2.06 Billion | 28.18 Million | 1.62 Billion |
| Debt repayment | -386.51 Million | -777.17 Million | -1.96 Billion | -2.52 Billion | -1.52 Billion | -303.08 Million |
| Dividends payments | -513.77 Million | -61.01 Million | -402.73 Million | -96.4 Million | -38.56 Million | -156.3 Million |
| Common Stock Repurchased | - | - | - | - | - | -76.87 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 260.56 Million | 126.5 Million | 1.46 Billion | 4.87 Billion | 1.69 Billion | 2.08 Billion |
| Accounts receivables | -247.61 Million | 413.4 Million | 182.69 Million | -582.55 Million | 21.49 Million | -157.04 Million |
| Accounts payables | 199.73 Million | -165.95 Million | -220.63 Million | 651.87 Million | -38.49 Million | 173.57 Million |
| Inventory | -146.32 Million | 176.54 Million | -426.52 Million | -342.93 Million | 2.42 Million | 85.19 Million |
| Other working capital | 20.45 Million | -59.22 Million | 10.82 Million | -28.98 Million | -24.5 Million | -9.7 Million |
| Cash at beginning of period | 1.87 Billion | 1.91 Billion | 3.09 Billion | 1.09 Billion | 663.95 Million | 231.59 Million |
| Cash at end of period | 1.08 Billion | 1.87 Billion | 1.91 Billion | 3.09 Billion | 1.09 Billion | 663.95 Million |
| Capital Expenditure | -774.14 Million | -896.86 Million | -2.58 Billion | -1.2 Billion | -356.68 Million | -441.09 Million |
| Effect of forex changes on cash | 20.56 Million | 59.63 Million | 48.06 Million | -87.64 Million | 4.33 Million | 25.19 Million |
| Net cash flow / Change in cash | -789.76 Million | -42.77 Million | -1.17 Billion | 2 Billion | 426.99 Million | 432.36 Million |
| Free Cash Flow | -847.03 Million | -402.39 Million | -336.21 Million | 2.46 Billion | 426.09 Million | 208.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -59.6 Million | -61.29 Million | -98.91 Million | -212.72 Million | -568.36 Million | -119.02 Million |
| Depreciation & Amortization | - | 141.96 Million | 141.96 Million | 524.51 Million | 524.51 Million | -257.6 Million |
| Deferred income taxes | - | - | - | - | -98.15 Million | 123.18 Million |
| Stock-based compensation | - | 4.89 Million | - | 20.45 Million | 20.45 Million | -12.13 Million |
| Change in working capital | - | -346.5 Million | - | -373.47 Million | -292.35 Million | 140.6 Million |
| Other non-cash items | 108.92 Million | 130.91 Million | 54.4 Million | 174.67 Million | 210.78 Million | 49.07 Million |
| Investing Cash Flow | -218.04 Million | -138.41 Million | -304.86 Million | -498.03 Million | -870.74 Million | -149.56 Million |
| Investments in PPE | -211.64 Million | -163.37 Million | -286.53 Million | -233.18 Million | -774.14 Million | -207.33 Million |
| Acquisitions | 1.71 Billion | 195.41 Thousand | 212 Thousand | 747.62 Thousand | 2.56 Million | 781.73 Thousand |
| Investment purchases | -44.68 Million | -80.23 Million | -36.77 Million | -253 Million | -398 Million | 88 Million |
| Sales/Maturities of investments | 37.78 Million | 104.21 Million | 18.22 Million | -5.87 Million | 298.83 Million | -41.22 Million |
| Other Investing Activities | 500.39 Thousand | 24.95 Million | -18.33 Million | -264.85 Million | -96.6 Million | 10.21 Million |
| Financing Cash Flow | 745.57 Million | -135.49 Million | 999.42 Million | 448.91 Million | 133.3 Million | 48.53 Million |
| Debt repayment | -33.97 Million | -142.07 Million | -133.69 Million | -189.49 Million | -386.51 Million | -171.95 Million |
| Dividends payments | -29.93 Million | -47.57 Million | -30.68 Million | -25.32 Million | -513.77 Million | -32.94 Million |
| Common Stock Repurchased | 30 Million | -30 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 741.54 Million | 54.16 Million | 896.4 Million | 284.74 Million | 260.56 Million | 253.43 Million |
| Accounts receivables | - | -290.2 Million | - | -247.61 Million | -247.61 Million | 100.74 Million |
| Accounts payables | - | - | - | - | 199.73 Million | 12.13 Million |
| Inventory | - | -61.19 Million | - | -146.32 Million | -146.32 Million | 39.85 Million |
| Other working capital | - | 4.89 Million | - | 20.45 Million | 20.45 Million | -12.13 Million |
| Cash at beginning of period | 1.43 Billion | 1.75 Billion | 1.08 Billion | 1 Billion | 1.87 Billion | 1.19 Billion |
| Cash at end of period | 2.01 Billion | 1.43 Billion | 1.75 Billion | 1.08 Billion | 1.08 Billion | 1 Billion |
| Capital Expenditure | -211.64 Million | -163.37 Million | -286.53 Million | -233.18 Million | -774.14 Million | -207.33 Million |
| Effect of forex changes on cash | 10.37 Million | 19.4 Million | 16.81 Million | 13.06 Million | 20.56 Million | -11.22 Million |
| Net cash flow / Change in cash | 577.78 Million | -318.98 Million | 666.85 Million | 76.92 Million | -789.76 Million | -188.16 Million |
| Free Cash Flow | -162.32 Million | -235.71 Million | -331.05 Million | -120.2 Million | -847.03 Million | -283.24 Million |
ACUS
MDP
BIOS
YTEN
FLTCF
023000